Latest news with #TerminalX
Yahoo
2 days ago
- Business
- Yahoo
Middle Eastern Market Insights: Commercial Bank International P.S.C And 2 Other Promising Penny Stocks
The Middle Eastern stock markets have been experiencing a positive momentum, with Gulf shares rising as geopolitical tensions ease and indices like Dubai's hitting 17-year highs. Amidst this backdrop, investors are exploring various opportunities that the market presents. Penny stocks, often associated with smaller or newer companies, remain an intriguing investment area due to their potential for growth at lower price points. This article will explore three such penny stocks in the Middle East that combine strong financials with promising prospects. Name Share Price Market Cap Financial Health Rating Terminal X Online (TASE:TRX) ₪4.929 ₪626.01M ★★★★★★ Thob Al Aseel (SASE:4012) SAR4.04 SAR1.62B ★★★★★★ Amanat Holdings PJSC (DFM:AMANAT) AED1.07 AED2.64B ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪4.722 ₪331.42M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.12 AED2.28B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY1.78 TRY1.92B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.14 AED386.93M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.52 AED10.76B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.846 AED515.19M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.53 ₪188.09M ★★★★★★ Click here to see the full list of 78 stocks from our Middle Eastern Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Commercial Bank International P.S.C. operates as a provider of banking products and services to individuals and businesses in the United Arab Emirates and internationally, with a market capitalization of AED1.51 billion. Operations: The company's revenue is primarily generated from its Wholesale Banking segment at AED253.01 million, followed by Real Estate at AED247.30 million, Treasury at AED53.75 million, and Retail Banking at AED53.34 million. Market Cap: AED1.51B Commercial Bank International P.S.C. presents a mixed picture for investors interested in penny stocks. Its Price-To-Earnings ratio of 8.4x is attractive compared to the local market average, suggesting potential value. The bank's seasoned board and management team add stability, while its funding primarily from low-risk sources enhances financial security. However, challenges include a high level of bad loans at 15.5% and lower net profit margins compared to last year. Despite these issues, CBI has demonstrated significant earnings growth over the past five years at 34.1% annually, although recent growth has slowed slightly below industry averages. Unlock comprehensive insights into our analysis of Commercial Bank International P.S.C stock in this financial health report. Gain insights into Commercial Bank International P.S.C's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi is a Turkish company specializing in the production and sale of foam sheets, with a market capitalization of TRY778.25 million. Operations: The company's revenue primarily comes from its Textile Operation, generating TRY12.64 billion, followed by Polyurethane Operations with TRY32.54 million. Market Cap: TRY778.25M Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi shows promise in the penny stock segment with its robust earnings growth of 127.5% over the past year, outpacing industry averages. The company's Price-To-Earnings ratio of 1.4x indicates potential undervaluation compared to the Turkish market average. Its financial health is supported by short-term assets exceeding liabilities and a satisfactory net debt to equity ratio of 31.5%. Recent earnings reports highlight improved profitability with a net income turnaround from a loss last year, though challenges remain with negative operating cash flow and high non-cash earnings levels impacting quality assessments. Click here to discover the nuances of Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi with our detailed analytical financial health report. Review our historical performance report to gain insights into Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi's track record. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Feat Fund Investments - Limited Partnership focuses on investing in the food, environment, agriculture, and technology sectors with a market cap of ₪6.68 million. Operations: The partnership generates revenue primarily from its venture capital segment, amounting to ₪3.51 million. Market Cap: ₪6.68M Feat Fund Investments - Limited Partnership, with a market cap of ₪6.68 million, has transitioned to profitability in the past year, reporting net income of ₪0.28 million for 2024 compared to a loss previously. Despite being debt-free and having short-term assets of ₪4.8 million exceeding liabilities, its revenue remains modest at ₪3.51 million from venture capital activities. The company's Return on Equity is low at 1.1%, indicating room for improvement in financial efficiency. The board's average tenure of 4.1 years suggests experienced governance, though management experience data is insufficient for comprehensive assessment. Dive into the specifics of Feat Fund Investments - Limited Partnership here with our thorough balance sheet health report. Assess Feat Fund Investments - Limited Partnership's previous results with our detailed historical performance reports. Unlock our comprehensive list of 78 Middle Eastern Penny Stocks by clicking here. Seeking Other Investments? Explore 25 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:CBI IBSE:MEGAP and TASE:FEAT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
4 days ago
- Business
- Yahoo
Middle Eastern Penny Stocks: 3 Picks With Market Caps Over US$50M
The Middle Eastern stock markets have recently experienced a positive shift, buoyed by the Iran-Israel ceasefire, which has improved investor sentiment and risk appetite across the region. As investors navigate these evolving conditions, penny stocks continue to capture attention due to their potential for growth at lower price points. Despite being considered a somewhat outdated term, penny stocks represent an investment area where smaller or newer companies with strong financials can offer significant opportunities for returns. Name Share Price Market Cap Financial Health Rating Terminal X Online (TASE:TRX) ₪4.959 ₪629.82M ★★★★★★ Menara Ventures Xl - Limited Partnership (TASE:MNRA) ₪2.716 ₪12.48M ★★★★★★ Thob Al Aseel (SASE:4012) SAR3.99 SAR1.6B ★★★★★★ Alarum Technologies (TASE:ALAR) ₪4.693 ₪329.39M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.09 AED2.16B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY1.83 TRY1.97B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.14 AED403.1M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.46 AED10.5B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.769 AED467.75M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.50 ₪185.86M ★★★★★★ Click here to see the full list of 79 stocks from our Middle Eastern Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Apex Investment PSC is engaged in the manufacturing, distribution, and sale of clinkers and cement products both within the United Arab Emirates and internationally, with a market capitalization of AED13.61 billion. Operations: The company's revenue is derived from catering (AED600.69 million), contracting (AED40.20 million), manufacturing (AED222.78 million), and facility management services (AED107.89 million). Market Cap: AED13.61B Apex Investment PSC, with a market capitalization of AED13.61 billion, recently reported a net loss of AED25.6 million for Q1 2025 despite generating sales of AED196.41 million. The company has managed to remain debt-free and maintains strong liquidity with short-term assets significantly exceeding liabilities. However, its profit margins have declined from 17.6% to 5.4% over the past year, impacted by a large one-off loss of AED79.7 million in the last twelve months ending March 31, 2025. Despite these challenges, Apex's experienced board and stable weekly volatility offer some stability amidst negative earnings growth. Take a closer look at Apex Investment PSC's potential here in our financial health report. Gain insights into Apex Investment PSC's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Ihlas Gazetecilik A.S. operates in the publishing industry by producing and distributing newspapers, books, encyclopedias, brochures, and magazines both in Turkey and internationally, with a market cap of TRY1.08 billion. Operations: The company generates revenue of TRY1.76 billion from its newspaper publishing segment. Market Cap: TRY1.08B Ihlas Gazetecilik A.S., with a market cap of TRY1.08 billion, has recently become profitable, though its earnings growth is challenging to compare due to past losses. The company reported Q1 2025 sales of TRY481.26 million but faced a net loss of TRY62 million, down from TRY111.3 million the previous year. While its debt-to-equity ratio has significantly improved over five years and short-term assets cover both short- and long-term liabilities, negative operating cash flow indicates that debt isn't well covered by cash flow alone. Despite these challenges, the board's experience provides some governance stability amidst financial volatility. Get an in-depth perspective on Ihlas Gazetecilik's performance by reading our balance sheet health report here. Review our historical performance report to gain insights into Ihlas Gazetecilik's track record. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Tgi Infrastructures Ltd, with a market cap of ₪185.86 million, operates in Israel's automotive industry by producing, processing, assembling, and marketing mechanical assemblies made of magnesium through its subsidiary. Operations: TASE:TGI generates revenue through its Infrastructure and Energy segment, which accounts for ₪82.70 million, and The Metal and Electrical Industries segment, contributing ₪81.87 million. Market Cap: ₪185.86M Tgi Infrastructures Ltd, with a market cap of ₪185.86 million, operates in Israel's automotive industry and has demonstrated robust earnings growth, surpassing the Auto Components industry's average. The company's recent quarterly results show increased sales of ₪43.04 million and net income rising to ₪5.49 million from last year's figures. Tgi's financial health is supported by strong short-term asset coverage over liabilities and satisfactory debt management, as evidenced by a reduced debt-to-equity ratio over five years. However, its 8.64% dividend yield isn't well covered by earnings or cash flows, indicating potential sustainability concerns for investors seeking stable income sources from this stock. Unlock comprehensive insights into our analysis of Tgi Infrastructures stock in this financial health report. Assess Tgi Infrastructures' previous results with our detailed historical performance reports. Embark on your investment journey to our 79 Middle Eastern Penny Stocks selection here. Want To Explore Some Alternatives? The end of cancer? These 24 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:APEX IBSE:IHGZT and TASE:TGI. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20-06-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Under US$900M To Consider
The Middle Eastern stock markets have recently experienced a retreat, influenced by ongoing geopolitical tensions and the U.S. Federal Reserve's monetary policy stance. Despite these challenges, investors continue to explore opportunities within the region, particularly in lesser-known segments such as penny stocks. Though 'penny stock' is an outdated term, it still represents companies that can offer significant value and potential returns when backed by solid financials. This article explores three such stocks that combine financial strength with promising prospects for growth. Name Share Price Market Cap Financial Health Rating Terminal X Online (TASE:TRX) ₪4.689 ₪595.53M ★★★★★★ Thob Al Aseel (SASE:4012) SAR3.75 SAR1.5B ★★★★★★ Amanat Holdings PJSC (DFM:AMANAT) AED1.05 AED2.61B ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪3.96 ₪277.94M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.00 AED2B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY1.83 TRY1.97B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.12 AED375.38M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.36 AED9.99B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.689 AED419.09M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.41 ₪179.16M ★★★★★★ Click here to see the full list of 95 stocks from our Middle Eastern Penny Stocks screener. Let's uncover some gems from our specialized screener. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Al Seer Marine Supplies and Equipment Company PJSC is involved in the management, maintenance, crewing, and operation of yachts in the United Arab Emirates, with a market cap of AED3.19 billion. Operations: The company's revenue is primarily derived from its Yachting segment, which generated AED916.18 million, followed by Commercial Shipping at AED301.05 million and IDT at AED64.18 million. Market Cap: AED3.19B Al Seer Marine Supplies and Equipment Company PJSC, while currently unprofitable, has made strategic moves to bolster its position in the maritime sector. The joint venture with B International Shipping & Logistics to form ASBI Shipping FZCO marks a significant step, securing AED 660 million in revenue through a 10-year charter. Despite increasing debt levels over five years, the company's short-term assets cover both short and long-term liabilities comfortably. The recent production agreement for high-speed interceptor vessels aligns with regional demand growth but highlights ongoing challenges in profitability amid fluctuating earnings and high share price volatility. Unlock comprehensive insights into our analysis of Al Seer Marine Supplies and Equipment Company PJSC stock in this financial health report. Gain insights into Al Seer Marine Supplies and Equipment Company PJSC's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Al Wathba National Insurance Company PJSC operates in the general insurance and reinsurance sectors both within the United Arab Emirates and internationally, with a market capitalization of AED745.20 million. Operations: The company's revenue is primarily derived from its Motor segment, which generated AED206.19 million, and its Investments segment, contributing AED97.50 million. Market Cap: AED745.2M Al Wathba National Insurance Company PJSC, with a market cap of AED745.20 million, faces challenges as it reported a net loss of AED16.05 million for Q1 2025 compared to the previous year. Despite this, the company maintains strong financial health with short-term assets exceeding both short and long-term liabilities significantly. The board's extensive experience supports stability amid fluctuating profit margins and earnings volatility impacted by large one-off items. Recent dividend distribution reflects commitment to shareholder returns, though the unstable dividend track record remains a concern alongside low return on equity and negative earnings growth over the past year. Take a closer look at Al Wathba National Insurance Company PJSC's potential here in our financial health report. Understand Al Wathba National Insurance Company PJSC's track record by examining our performance history report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Allmed Solutions Ltd develops, manufactures, and markets minimally invasive medical products across various disciplines both in Israel and internationally, with a market cap of ₪28.73 million. Operations: No specific revenue segments are reported for Allmed Solutions Ltd. Market Cap: ₪28.73M Allmed Solutions Ltd, with a market cap of ₪28.73 million, operates without debt and maintains a strong financial position as its short-term assets of ₪43.8 million exceed both short and long-term liabilities. Despite being pre-revenue with less than US$1 million in revenue, the company has a cash runway exceeding three years based on current free cash flow. The management team and board are experienced, contributing to stability despite high share price volatility over recent months. However, Allmed remains unprofitable with increasing losses over five years at 61.2% annually and negative return on equity at -20.83%. Navigate through the intricacies of Allmed Solutions with our comprehensive balance sheet health report here. Evaluate Allmed Solutions' historical performance by accessing our past performance report. Jump into our full catalog of 95 Middle Eastern Penny Stocks here. Ready For A Different Approach? AI is about to change healthcare. These 22 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:ASM ADX:AWNIC and TASE:ALMD. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17-06-2025
- Business
- Yahoo
Middle Eastern Penny Stocks Spotlight: Gulf Pharmaceutical Industries P.S.C And Two More
The Middle Eastern stock markets have recently shown resilience, rebounding amid geopolitical tensions between Israel and Iran. In this context, investors are increasingly interested in exploring opportunities beyond the well-known giants, turning their attention to penny stocks. Although the term 'penny stocks' might seem outdated, these smaller or newer companies can offer a mix of affordability and growth potential when backed by strong financials. Name Share Price Market Cap Financial Health Rating Terminal X Online (TASE:TRX) ₪4.329 ₪549.81M ★★★★★★ Menara Ventures Xl - Limited Partnership (TASE:MNRA) ₪2.719 ₪12.49M ★★★★★★ Thob Al Aseel (SASE:4012) SAR3.83 SAR1.53B ★★★★★★ Alarum Technologies (TASE:ALAR) ₪3.958 ₪277.8M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.04 AED2.08B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY1.72 TRY1.85B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.24 AED375.38M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.40 AED10.12B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.745 AED453.15M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.329 ₪173.14M ★★★★★★ Click here to see the full list of 94 stocks from our Middle Eastern Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Gulf Pharmaceutical Industries P.S.C., operating with its subsidiaries, produces and markets a range of pharmaceutical, cosmetic, and medical products in the UAE, GCC countries, and globally, with a market cap of AED1.46 billion. Operations: The company's revenue segments include Planet with AED732.9 million and Manufacturing with AED864.9 million. Market Cap: AED1.46B Gulf Pharmaceutical Industries P.S.C. has demonstrated significant financial improvement, becoming profitable last year and reporting a substantial increase in net income for Q1 2025 at AED140.9 million, compared to AED1.9 million the previous year. The company's revenue segments are strong, with manufacturing contributing AED864.9 million annually. Despite high share price volatility over the past three months, its debt is well-managed with a satisfactory net debt to equity ratio of 4.8%. However, interest coverage remains low at 1.4x EBIT, indicating potential challenges in meeting interest obligations efficiently without improved earnings or cost management strategies. Get an in-depth perspective on Gulf Pharmaceutical Industries P.S.C's performance by reading our balance sheet health report here. Review our growth performance report to gain insights into Gulf Pharmaceutical Industries P.S.C's future. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Sinpas Gayrimenkul Yatirim Ortakligi, originally established as Sinpas Insaat in 2006 and transformed into a Real Estate Investment Trust (REIT) in 2007, operates within the real estate sector with a market capitalization of TRY15.16 billion. Operations: The company generates revenue primarily from its Residential Real Estate Developments segment, amounting to TRY12.64 billion. Market Cap: TRY15.16B Sinpas Gayrimenkul Yatirim Ortakligi has shown robust earnings growth, with a significant 86.4% increase over the past year, surpassing its five-year average of 31.9%. Despite this growth, recent financial results indicate a decline in net income and sales for Q1 2025 compared to the previous year. The company's debt management is strong, with a reduced debt-to-equity ratio of 14.5%, although interest coverage remains low at 2.1x EBIT. While trading below estimated fair value by 23%, Sinpas benefits from seasoned management and board experience but faces challenges in maintaining profit margins amidst large one-off gains impacting results. Navigate through the intricacies of Sinpas Gayrimenkul Yatirim Ortakligi with our comprehensive balance sheet health report here. Explore historical data to track Sinpas Gayrimenkul Yatirim Ortakligi's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Alarum Technologies Ltd. offers web data collection solutions across multiple regions including the Americas, Europe, Southeast Asia, the Middle East, and Africa with a market cap of ₪277.80 million. Operations: The company does not report specific revenue segments. Market Cap: ₪277.8M Alarum Technologies Ltd. has demonstrated a transition to profitability, with earnings growth of 35% annually over the past five years. The company recently raised its Q2 2025 revenue guidance to US$8.8 million, indicating positive momentum despite a decrease in Q1 sales and net income compared to the previous year. Alarum's financial health is robust, with more cash than total debt and strong interest coverage by operating cash flow. However, it faces legal challenges from a class action lawsuit filed in New Jersey, which could impact investor sentiment moving forward. Take a closer look at Alarum Technologies' potential here in our financial health report. Evaluate Alarum Technologies' prospects by accessing our earnings growth report. Reveal the 94 hidden gems among our Middle Eastern Penny Stocks screener with a single click here. Curious About Other Options? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:JULPHAR IBSE:SNGYO and TASE:ALAR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
10-06-2025
- Business
- Yahoo
Middle Eastern Penny Stocks To Watch In June 2025
As the Middle Eastern markets continue to navigate global economic uncertainties, UAE stocks have recently shown resilience, ending higher amid anticipation of U.S.-China trade talks. This backdrop provides a fertile ground for exploring investment opportunities in lesser-known areas of the market. While the term 'penny stocks' may seem outdated, these low-priced shares often represent smaller or emerging companies that can offer significant growth potential when backed by solid financials. Name Share Price Market Cap Financial Health Rating Terminal X Online (TASE:TRX) ₪4.362 ₪555.01M ★★★★★★ Menara Ventures Xl - Limited Partnership (TASE:MNRA) ₪2.719 ₪12.49M ★★★★★★ Thob Al Aseel (SASE:4012) SAR4.02 SAR1.6B ★★★★★★ Alarum Technologies (TASE:ALAR) ₪3.47 ₪197.56M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.12 AED2.24B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY1.79 TRY1.93B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.13 AED375.38M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.41 AED10.33B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.736 AED447.67M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.258 ₪174.26M ★★★★★★ Click here to see the full list of 94 stocks from our Middle Eastern Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Bank Of Sharjah P.J.S.C., along with its subsidiaries, offers commercial and investment banking products and services in the United Arab Emirates, with a market cap of AED2.58 billion. Operations: No specific revenue segments are reported for this company. Market Cap: AED2.58B Bank Of Sharjah P.J.S.C. has demonstrated a notable improvement in profitability, with net income rising to AED 116.35 million for Q1 2025 from AED 80.67 million the previous year, supported by a significant one-off gain of AED101.9M. The bank's financial structure is primarily backed by low-risk customer deposits, accounting for 82% of its liabilities, and maintains appropriate loan levels with a Loans to Deposits ratio of 77%. However, challenges include a high level of non-performing loans at 7.6% and an inexperienced management team with an average tenure of just 0.5 years. Click here and access our complete financial health analysis report to understand the dynamics of Bank Of Sharjah P.J.S.C. Gain insights into Bank Of Sharjah P.J.S.C's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Amanat Holdings PJSC, along with its subsidiaries, invests in education and healthcare companies both within the United Arab Emirates and internationally, with a market cap of AED2.66 billion. Operations: The company generates revenue from two primary segments: Education, contributing AED460.94 million, and Healthcare, accounting for AED362.38 million. Market Cap: AED2.66B Amanat Holdings PJSC recently reported Q1 2025 earnings with sales of AED 240.73 million, up from AED 213.5 million the previous year, though net income slightly decreased to AED 37.67 million. The company's financial health is supported by short-term assets exceeding both short and long-term liabilities, and a cash position stronger than its total debt, indicating sound liquidity management. Despite a low return on equity at 6%, Amanat's earnings growth of over 166% outpaces industry averages significantly, although the dividend yield of 4.3% is not well covered by free cash flows, suggesting caution for income-focused investors. Get an in-depth perspective on Amanat Holdings PJSC's performance by reading our balance sheet health report here. Explore historical data to track Amanat Holdings PJSC's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Bonus BioGroup Ltd. is a clinical-stage biotechnology company focused on developing tissue engineering and cell therapy products, with a market cap of ₪254.61 million. Operations: Bonus BioGroup Ltd. currently has no reported revenue segments. Market Cap: ₪254.61M Bonus BioGroup Ltd., a clinical-stage biotechnology company, remains pre-revenue with earnings growth of 2.7% per year over the past five years despite ongoing losses. The company's market cap stands at ₪254.61 million, and it is debt-free but faces short-term and long-term liabilities that exceed its assets. Recent efforts to bolster financial stability include a $20 million follow-on equity offering in May 2025, which may extend its cash runway beyond the current three months forecasted based on free cash flow estimates. Despite high volatility in share price, shareholder dilution has been minimal over the past year. Take a closer look at Bonus BioGroup's potential here in our financial health report. Assess Bonus BioGroup's previous results with our detailed historical performance reports. Click here to access our complete index of 94 Middle Eastern Penny Stocks. Contemplating Other Strategies? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:BOS DFM:AMANAT and TASE:BONS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
